Increased vascular endothelial growth factor (VEGF), VEGF receptor 2 (VEGFR2), and CD31 (endothelial cell marker) expressions in mesentery of portal hypertensive mice have also been found, which provided the evidence of mesenteric angiogenesis in portal hypertension [1]. Here, VEGFA is linked to liver disorder.